COPD clinical trials in New Jersey
7 studies for COPD are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Mullica Hill
- Research Site, Toms River
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 2, 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Bioluminux Clinical Research - Hamilton, New Jersey- Site Number : 8400037, Hamilton
- Rutgers Institute For Infectious & Inflammatory Diseases (I3d)- Site Number : 8400093, Newark
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 1, 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Sanmora Bespoke Clinical Research Solutions- Site Number : 8400144, East Orange
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 22, 2026 · NCT07190209A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Millville
- Research Site, Sewell
- Research Site, Toms River
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305COPD Exacerbation Follow Up
- Cooper University Health Care, Cherry Hill
RecruitingObservational study
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT07118306Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Moorestown
- GSK Investigational Site, Sewell
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Apr 9, 2026 · NCT06961214Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Inspira Medical Center, Mullica Hill
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.